Ken Field is a partner at Hogan Lovells in the global regulatory team, based in Washington. D.C. He is an antitrust partner and health care antitrust practice leader in the firm’s Washington, D.C. office. He advises clients on all aspects of antitrust and competition law and focuses on representing clients before the U.S. Department of Justice, the Federal Trade Commission, and state antitrust enforcement authorities. He has a broad range of experience in health care, mergers and acquisitions, government investigations, litigation, counseling, and compliance programs and has represented clients from numerous industries, including health care, retail, consumer products, telecommunications, transportation, energy, and more. Ken Field earned his J.D. and MBA from the Georgetown University Law Center and a B.A. in Political Science from the University of California, San Diego. Before joining Hogan Lovells, he worked at Jones Day as an antitrust partner and co-chair of the firm’s global Health Care Practice. Previously, he worked at the Bureau of Competition of the Federal Trade Commission and the Antitrust Division of the U.S. Department of Justice.
139
On July 19, 2023 the Federal Trade Commission (FTC) and Department of Justice (DOJ) (“the agencies”) released their 2023 Draft Merger Guidelines (the “2023 draft guidelines” or the “revised guidelines”). The publication of the revised guidelines—currently available for public comment until (...)
45
On July 19, 2023 the Federal Trade Commission (FTC) and Department of Justice (DOJ) (“the agencies”) released their 2023 Draft Merger Guidelines (the “2023 draft guidelines” or the “revised guidelines”). The publication of the revised guidelines—currently available for public comment until (...)
92
In Short The Development : Congress unanimously passed and before leaving office, President Trump signed into law, the Competitive Health Insurance Reform Act ("CHIRA"). CHIRA limits application of the McCarran-Ferguson Act, an exemption from the federal antitrust laws, as it relates to the (...)
46
In a decision that extends the FTC’s winning streak in the courts of appeals in healthcare provider merger cases, the Eighth Circuit affirmed the Federal Trade Commission’s ("FTC") bid to enjoin Sanford Health’s acquisition of Mid Dakota Clinic ("MDC"). This decision follows almost three years (...)
122
This article has been nominated for the 2020 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. In Short The Situation : The Federal Trade Commission ("FTC") recently filed a rare monopolization case, alleging that a health information technology company (...)
186
The Federal Trade Commission ("FTC") has released a draft Strategic Plan for Fiscal Years 2014-2018 (the "2014 Plan"). Despite the ambitious title, the 2014 Plan actually focuses on a small number of procedural issues. It provides no indication of the FTC’s likely substantive agenda or (...)
379
This article has been nominated for the 2014 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. The Fourth Circuit Court of Appeals has ruled that North Carolina’s Dental Board cannot ban non-dentists from offering teeth-whitening service, upholding the (...)
312
The U.S. Department of Justice ("DOJ") has reached a settlement with Anheuser-Busch InBev ("ABI") and Grupo Modelo S.A.B. de C.V. ("Modelo"), requiring ABI to divest Modelo’s entire U.S. business to Constellation Brands Inc. ("Constellation"). The consent decree provides for a straightforward (...)
